Fundraising FoxViking Global
Crossover fundStamford · Growth–Late Stage · 61 people tracked
Find your way into Viking Global
Sign up to find every way you can get introduced to Viking Global
- Your email: who you already know at Viking Global, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Viking Global team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Viking Global applies a long-term, fundamental, research-based investment approach aimed at generating the highest risk-adjusted returns for its investors. The firm evaluates a broad spectrum of opportunities across global markets and concentrates capital in the ideas it finds most attractive. Its process is described as time-tested and research-intensive, supported by a culture of intellectual honesty and a commitment to both investment and operational excellence. Viking invests across public equities, private equities, and credit and structured capital, positioning itself as an enduring asset manager focused on its investors, people, and communities.
Source: firm website, verified Oct 2, 2026.
Team · 61 people
from the firm's website & public directories
What they invest in
from 71 of 130 portfolio companiesBiotech ×42Healthtech ×35AI & Machine Learning ×16Medical Devices ×15SaaS ×12Enterprise Software ×7Deep Tech ×6Digital Health ×6
HQs:United States×59Brazil×1Israel×1Mexico×1
Who they back
founder profiles across 52 portfolio companiesFounding team size:solo founder×232 founders×173 founders×64+ founders×6
Where their founders studiedfrom 50 founders with education data
Massachusetts Institute of Technology ×12University of California, Berkeley ×5Harvard University ×4Stanford University ×4The Wharton School ×3Instituto Superior Técnico ×2The University of Texas at Austin ×2University of California, San Francisco ×2
What their founders studiedfrom 54 founders with field-of-study data
Engineering ×17Computer Science ×16Life Sciences ×11Medicine ×8Economics ×7Business & Management ×5Finance & Accounting ×5Chemistry ×4
Where their founders worked beforefrom 55 founders with career history
Google ×3Broad Institute of MIT and Harvard ×2Harvard Medical School ×2Microsoft ×2Morgan Stanley ×2Nextech Invest ×2OrbiMed ×2PayPal ×2
Accelerator rootsportfolio companies that came through a program
23 founders hold a PhD · 11 hold an MBA (of 55 with degree data)
Investments · 130 tracked
founders shown can be your intro path
4DMT is a late-stage biotechnology company that develops gene delivery systems and genetic therapeutics targeting specific tissue types for various diseases.
BiotechHealthtechEmeryville, US
David Kirn(Executive Officer, Director)inDavid Schaffer(Director)inTheresa Janke(Executive Officer)in
BoardSharon Tetlow(Director)Margi McLoughlin(Director)
Co-investorsAmzak HealthBerkeley CatalystBOLD LongevityChiesi VenturesPappas CapitalPfizer Venture Investments+7 more
Adaptive Biotechnologies applies the genetics of the adaptive immune system to diagnostics and therapeutics, translating immune-system data into clinical insights for clinicians and biopharma companies.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSeattle, US
Chad Robins(Chief Executive Officer, Co-founder, Chairman of the Board)inHarlan Robins(Co-founder; Chief Scientific Officer until 2026)inKathleen Determann(Executive Officer)inDean Schorno(Executive Officer)inChris Carlson(Executive Officer)Kyle Piskel(Chief Financial Officer)in
Co-investorsDecheng CapitalFMG CapitalForesite CapitalKhosla VenturesCasdin CapitalOrbiMed
aTyr is a clinical-stage biotechnology company developing therapies derived from tRNA synthetase biology to treat fibrosis and inflammation, with its lead candidate efzofitimod in clinical trials for interstitial lung disease.
BiotechHealthtechMedical DevicesSan Diego, US
Paul Schimmel(Non-Management Director)John D. Mendlein(Executive Officer, Director)David Weiner(Executive Officer)inFrederic Chereau(Executive Officer)
BoardAmir Nashat(Non-Management Director)inAkkaraju Srinivas(Non-Management Director)
Co-investorsCardinal PartnersEcoR1 CapitalSofinnova VenturesDomain AssociatesDomain PartnersPolaris Partners+2 more
Edgewise Therapeutics discovers and develops small molecule medicines targeting muscle proteins to treat neuromuscular and cardiac diseases, including sevasemten for muscular dystrophies and EDG-7500 for cardiomyopathy, leveraging a proprietary drug discovery platform based on muscle physiology and high-throughput functional assays.
BiotechDigital HealthBoulder, US
Kevin Koch(Executive Officer, Director)inAlan Russell(Director)inBadreddin Edris(Director and Co-Founder)inKenneth Harrison(Director)
BoardPeter Thompson(Director)inJonathan Root(Director)in
Co-investorsBoulder VenturesForesite CapitalOrbiMedUS Venture PartnersWellington ManagementDeerfield Management Company+1 more
Editas Medicine develops gene editing medicines using CRISPR/Cas9 and CRISPR/Cas12a technology to treat serious diseases including blood disorders, cardiovascular conditions, and cancer.
BiotechDeep TechMedical DevicesCambridge, US
Feng Zhang(Scientific Founder, Core Member, Broad Institute of MIT and Harvard)inGeorge Church(Scientific Founder, Professor of Genetics, Harvard University and MIT)inKeith Joung(Scientific Founder, Professor of Pathology, Harvard Medical School)inDavid Liu(Scientific Founder, Professor of Chemistry and Chemical Biology, Harvard University)inKatrine Bosley(Executive Officer, Director)inVic Myer(Executive Officer)in
Co-investorsEcoR1 CapitalGV (Google Ventures)Sofinnova VenturesAtlas VentureDeerfield Management CompanyFlagship Ventures+1 more
Ginkgo Bioworks builds autonomous labs that accelerate bioengineering for applications in pharmaceutical, agricultural, and industrial biotechnology.
AgTechAI & Machine LearningBiotechDeep TechHealthtechRoboticsBoston, US
Jason Kelly(Co-founder and CEO)inReshma Shetty(Co-founder; President, Chief Operations Officer)inBarry Canton(Co-founder)inAustin Che(Co-founder)inTom Knight(Founder; Ginkgo Fellow)inBartholomew Canton(Executive Officer)
Co-investors11.2 CapitalAllen Institute for AI (AI2) IncubatorAzure Capital PartnersB3 HoldingBlue Owl CapitalCannage Capital+60 more
ORIC Pharmaceuticals is a clinical-stage oncology company developing therapies aimed at overcoming cancer treatment resistance, including innate, acquired, and bypass resistance.
BiotechHealthtechSouth San Francisco, US
Richard Heyman(Chairman, Founder, Scientific Advisory Board)inCharles Sawyers(Founder, Scientific Advisory Board)Scott Lowe(Founder, Scientific Advisory Board)Dominic Piscitelli(Chief Financial Officer)inPratik Multani(Chief Medical Officer)inJacob Chacko(President, Chief Executive Officer and Board Member)in
Co-investorsEcoR1 CapitalNew Enterprise Associates (NEA)Nextech InvestTaiho Ventures, LLCThe Column GroupOrbiMed
Oruka is a biopharmaceutical company developing monoclonal antibody therapies aimed at treating plaque psoriasis, psoriatic arthritis, and other dermatologic and inflammatory conditions with fewer annual doses.
BiotechHealthtech
Lawrence Klein(Chief Executive Officer and Director)in
Co-investorsSR One Capital Management
PepGen is a clinical-stage biotech company developing oligonucleotide therapies for neuromuscular and neurological diseases using its Enhanced Delivery Oligonucleotide (EDO) platform to improve tissue penetration and uptake in muscle tissues.
AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US
James McArthur(Executive Officer, Director)inNoel P. Donnelly(Chief Financial Officer)inJoseph D. Vittiglio(Chief Business & Legal Officer and Secretary)inKasra Kasraian(Chief Technical Officer)in
BoardRamin Farzaneh-Far(Director)inJoshua Resnick(Director)
Co-investorsOxford Science EnterprisesRA Capital
PROCEPT BioRobotics develops robotic-assisted surgical technology for men's health, focused on treating benign prostatic hyperplasia (BPH).
HealthtechMedical DevicesRoboticsRedwood City, US
Nikolai Aljuri, Ph.D.(Executive Officer, Director)Larry L. Wood(President, Chief Executive Officer & Director)Kevin Waters(EVP, Chief Financial Officer)inAlaleh Nouri(EVP, Chief Legal Officer & Corporate Secretary)in
BoardFred Moll(Director)inColby Wood(Director)
Co-investorsLongitude CapitalSonder CapitalSonder Futures
Rallybio is a clinical-stage biotech company developing therapies for people with severe and rare diseases, with a pipeline focused on complement dysregulation and hematology.
BiotechHealthtechNew Haven, US
Stephen Uden(Founder)inMartin W. Mackay(Chairman of the Board of Directors)inJon(Chief Financial Officer)
Co-investors5AM VenturesCanaan PartnersConnecticut InnovationsF-Prime CapitalMitsui Global InvestmentPivotal Life Sciences+2 more
Sionna Therapeutics is a biopharmaceutical company founded in 2019 that develops small-molecule therapies for cystic fibrosis by targeting and stabilizing NBD1, the domain of the CFTR protein where the common ΔF508 mutation occurs.
BiotechHealthtechMedical Devices
Greg(Co-founder & Senior Vice President of Discovery Research)Mark(Co-founder & Senior Vice President of Medicinal Chemistry)Mike(President & CEO)Charlotte(Chief Medical Officer)Elena(Chief Financial Officer)Caroline(Chief Business Officer)
Co-investorsAtlas VentureOrbiMedRA Capital
Trevi Therapeutics is a clinical-stage biopharmaceutical company developing Haduvio (oral nalbuphine ER), an investigational therapy for chronic cough that targets the central and peripheral cough reflex arc.
BiotechHealthtechNew Haven, US
Thomas Sciascia(Executive Officer)Jennifer Good(Co-Founder, President and CEO)inThomas Sciascia, M.D.(Co-Founder, Chief Scientific Officer)Lisa Delfini(Executive Officer)inWilliam Forbes(Executive Officer)inMichael Heffernan(Director)in
Co-investorsAPERTURE Venture PartnersFrazier Life SciencesNew Enterprise Associates (NEA)Pivotal Life SciencesOmega Funds
Uber operates a multi-sided platform providing ride-sharing, food delivery, freight logistics, and business fleet management services across various global markets.
Logistics & Supply ChainMarketplacesMobility & TransportationSan Francisco, US
Travis Kalanick(Co-founder; CEO until 2017)Garrett Camp(Co-founder)inGautam Gupta(Executive Officer)inJeffrey Holden(Executive Officer)David Plouffe(Executive Officer)inEmil Michael(Executive Officer)in
Co-investors137 Ventures3Spoke Capital408 VenturesA*ACME CapitalAcross Capital Partners+89 more
Verastem Oncology is a biopharmaceutical company that discovers and develops drugs to treat cancer patients.
BiotechMedical DevicesNeedham, US
Robert WeinbergRICHARD ALDRICH(Director)AMY C. CAVERS(Executive Officer)inCATHY CAREW(Executive Officer)inJONATHAN PACHTER(Executive Officer)inROB GAGNON(Executive Officer)in
Co-investorsBessemer Venture PartnersCardinal PartnersForesite CapitalLightstone VenturesLongwood FundOberland Capital+1 more
Algen Biotechnologies discovers and develops small molecule therapeutics for cancer and inflammatory diseases using CRISPR, RNAi, and machine learning to decode functional gene networks and predict drug responses.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSan Francisco, US
Chun-Hao Huang(Founder)inChristine Du(Founder)inJennifer DoudnaDr. Jeff Whitten(Chief Scientific Officer)
Co-investorsCota CapitalDraper AssociatesLifespan Vision VenturesRebel FundY CombinatorSequoia Capital
AlphaSense provides a financial research and market intelligence platform that combines standardized financials, consensus estimates, filings, earnings transcripts, broker research, and AI-generated answers for analyzing and benchmarking companies.
AI & Machine LearningData & InfrastructureEnterprise SoftwareFintechNew York, US
Rajmohan Neervannan(Related person at the time of the offering.)Raj Neervannan(Chief Technology Officer & Co-Founder)inJaakko (Jack) Kokko(Founder)inJack Kokko(Chief Executive Officer & Founder)inKiva Kolstein(President & Chief Revenue Officer)inHeather Zynczak(Chief Marketing Officer)in
Co-investorsAlkeon InnovationBlue Owl CapitalBond Capital ManagementBrama One VenturesCapitalGCentana Growth Partners+11 more
Biopharmaceutical company discovering and developing novel biologics, protein, and peptide therapeutics.
South San Francisco, US
Co-investorsBain Capital Life SciencesFrazier Life SciencesLongitude CapitalBlackRockCasdin CapitalFranklin Templeton+6 more
Apeel Sciences develops plant-based coatings derived from fatty acids and glycerides—ingredients naturally found in plant peels and seeds—that are applied to fresh fruits and vegetables to extend shelf life, preserve flavor and nutrients, and reduce reliance on refrigeration, pesticides, waxes, and plastics.
AgTechCircular EconomyCleantechClimate TechFoodTech
LouJames Rogers(Founder)inJenny Du(Founder)in
Co-investors3cubed VenturesA-Rod CorpAgFunderAndreessen HorowitzATEL VenturesBild Alternative Investments Corporation+19 more
Architect Therapeutics is a drug discovery company that uses C-H bond activation chemistry to synthesize novel 3D small-molecule scaffolds and screen them against difficult-to-drug targets.
BiotechDeep TechSan Diego, US
Jin-Quan Yu(Founder)inJin-Quan Yu, Ph.D.(Scientific Founder)Ben Cravatt Ph.D.(Scientific Founder)Rich Heyman, Ph.D.(Scientific Founder)Angie You, Ph.D.(Chief Executive Officer)
Co-investorsFrazier Life SciencesOrbiMed
Arctic Wolf provides managed detection and response (MDR) services with 24x7 security teams that detect, investigate, and respond to threats using an open XDR platform processing trillions of events weekly.
AI & Machine LearningCybersecurityEnterprise SoftwareSaaSEden Prairie, US
Brian NeSmith(Founder & CEO)in
Co-investors1435 Capital33NArtisanal VenturesBlue Cloud VenturesBlue Owl CapitalBright Pixel Capital+21 more
Areteia Therapeutics was a clinical-stage biotechnology company that is no longer operating.
BiotechChapel Hill, US
Robin Walker(Executive Officer)inChristopher Courts(Executive Officer)inJorge Bartolome(Executive Officer, Director)in
BoardBenjamin Gomez(Director)Adam Koppel(Director)inMichael E. Bozik(Director)
Co-investorsARCH Venture PartnersBain Capital Life SciencesGV (Google Ventures)Solas BioVenturesAccess BiotechnologyMaverick Capital+3 more
AssetWatch provides cloud-based asset monitoring software and sensor technology to help manufacturing and industrial facilities prevent unplanned equipment downtime.
Advanced ManufacturingEnterprise SoftwareIoTSaaSWesterville, US
William Zell(Executive Officer, Director)William Ruff(Executive Officer)inRobert Lee(Director)inTad Dritz(VP of Development)inJeff Haskett(COO)inBrian Graham(Executive Officer, Director)in
Co-investorsCerity Partners VenturesG2 Venture PartnersHarmonic Growth PartnersJobsOhio VenturesMonte Carlo CapitalOUP (Osage University Partners)+5 more
Developer of a surgical robotic system for minimally invasive endoscopy and laparoscopy
Co-investorsBeast VenturesLux CapitalMithril Capital ManagementPractica CapitalSBI Investment Korea Co. Ltd.Sonder Capital+2 more
BiomEdit develops microbiome-based products for animal health using high-throughput microbiology and AI-powered predictive algorithms.
AgTechAI & Machine LearningBiotechFishers, US
Bruce Schelkopf(Executive Officer)inAaron Schacht(CEO)in
BoardPatrick James(Director)Paul Casady(Director)Brett Wong(Director)inBarbara Bodem(Director)
Co-investorsAgriZeroNZAnterra CapitalElevate Ventures
Birchbox curates and delivers personalized beauty products monthly to consumers, offering discovery of curated beauty and grooming items.
ConsumerDirect to ConsumerE-commerceWellness & FitnessNew York, US
KATIA BEAUCHAMP(Executive Officer, Director)MICHAEL MUTONE(Executive Officer)in
BoardMARK SHULMAN(Director)JESSE PUJJI(Director)CLAIRE HOUGH(Director)
Co-investorsBullishElizabeth Street VenturesGlynn Capital ManagementGrace Beauty CapitalLerer HippeauRed Swan Ventures+2 more
Advanced ManufacturingAgTechBrisbane, US
Jamie Bacher(Founder)inAdam Paul Arkin(Founder)in
BoardErkki Aaltonen(Director)in
Co-investorsCompoundKickstart InnovationSaltagen VenturesUniversal Materials IncubatorY CombinatorYara Growth Ventures+10 more
BridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support.
BiotechHealthtech
Co-investorsAisling CapitalAmzak HealthEcoR1 CapitalFrazier Life SciencesHEALTHCARE ROYALTY PARTNERSLongwood Fund+2 more
Checkerspot uses microalgae precision fermentation to produce specialized lipids and fats, including a bio-equivalent source of the sn-2 palmitate fat found in mother's milk, rare bioactive fatty acids, and tropical fat alternatives.
BiotechClimate TechFoodTechNew MaterialsAlameda, US
Scott Franklin(Executive Officer, Director)inCharles Dimmler(Executive Officer, Director)inJohn Krzywicki(CEO)inLayla Ward(CFO)inCasey Lippmeier(CTO)inLeon Parker(SVP, Molecular Biology)in
Co-investorsBaruch Future VenturesBreakout VenturesCavallo VenturesBuilders VCKdT VenturesPlug and Play Ventures+3 more
City Therapeutics develops RNAi-based medicines targeting rare, specialty, and prevalent diseases using engineered trigger molecules and precision delivery ligands.
BiotechMedical DevicesCambridge, US
Mark Keating, MD(Co-founder)Kotaro Nakanishi, PhD(Co-founder)Yukihide Tomari, PhD(Co-founder)Phillip Zamore, PhD(Co-founder)Andy Orth(Chief Executive Officer)in
Co-investorsAN Venture PartnersARCH Venture PartnersSofinnova VenturesAltitude Ventures Management, LlcCasdin CapitalFidelity Investments+4 more
Clari, merged with Salesloft, provides an AI-powered system for revenue prediction and optimization serving enterprise customers.
AI & Machine LearningSaaSSales TechSunnyvale, US
Venkat Rangan(Executive Officer, Director)inAndy Byrne(Executive Officer, Director)in
BoardEnrique Salem(Director)inAjay Agarwal(Director)inAaref Hilaly(Director)inMark Gainey(Director)in
Co-investorsB Capital GroupB4 CapitalBain Capital VenturesHubSpot VenturesLevel EquityMadrona Venture Group+13 more
.jpeg){kind=logo}
Clip provides financial technology products and services to help businesses in Mexico access modern fintech solutions and grow their operations.
FintechRetail TechSaaSMexico City, MX
Vilash PoovalainAdolfo Babatzin
Co-investors500 GlobalAccionCanvas VenturesCapria VenturesDalus CapitalEndurance28+11 more
Cloudbeds provides a property management system (PMS) and growth platform for hospitality businesses, including hotels and other accommodations.
Cloud ComputingPropTechSaaSTravel & Hospitality
Co-investorsClearVision EquityCounterpart VenturesKeshif VenturesMoore Venture PartnersPasadena AngelsPeakSpan Capital Partners+4 more
Cognism is a B2B sales intelligence platform that provides accurate, compliance-focused contact and company data for revenue and go-to-market teams.
Data & InfrastructureSaaSSales Tech
James Isilay(Founder)in
Co-investorsInnvotec Ltd.PeakSpan Capital PartnersSouth Central VenturesVenture FoundersVolution VenturesAtlantic Vantage Point+7 more
Color Health operates a nationwide virtual cancer clinic delivering oncologist-led care, screening, and treatment management for employer, union, health plan, and public sector populations.
AI & Machine LearningDigital HealthHealthtechSan Francisco, US
Othman Laraki(CEO)in
Co-investors8VCAliya Capital PartnersComcast VenturesCRV (Charles River Ventures)Dria VenturesForesite Capital+14 more
Credit Karma is an AI-powered personal finance platform that provides free credit scores, credit monitoring, cashflow insights, and financial marketplace services to help consumers understand and manage their finances.
AI & Machine LearningConsumerFintechSan Francisco, US
Kenneth Lin(Founder & CEO)inNichole MustardinRyan Gracianoin
Co-investors500 GlobalArcher Capital GroupArcher Venture CapitalCapitalGEQUIAMFelicis Ventures+11 more
Day One is a biopharmaceutical company that develops first- or best-in-class targeted medicines for children and adults with life-threatening diseases, with a focus on cancers such as pediatric brain tumors.
BiotechHealthtechSouth San Francisco, US
Jeremy Bender(Executive Officer, Director)
BoardMichael Gladstone(Director)inDerek DiRocco(Director)inJulie Papanek Grant(Director)inJohn Josey(Director)inDaniel Becker(Director)
Co-investorsAccess BiotechnologyAtlas VentureCanaan PartnersAccess IndustriesRA CapitalThe Column Group
Diagonal Therapeutics develops multi-specific clustering antibody therapeutics that bind multiple cell-surface receptors to activate or inhibit dysregulated signaling pathways underlying chronic diseases.
AI & Machine LearningBiotechHealthtechWatertown, US
Co-investorsAtlas VentureEcoR1 CapitalFrazier Life SciencesRA CapitalRV Invest GmbHSanofi Ventures
Dock provides cloud-native payments and banking infrastructure that lets companies offer digital accounts, branded (white label) cards, Pix, acquiring, and anti-fraud/identity verification services.
Data & InfrastructureFintechSaaS
Co-investorsConfraparLightrockRiverwood CapitalViking Global Investors
Drew Marine provides marine and energy solutions including cargo hold systems, fuel management, water treatment, maintenance, refrigeration, and recreational products for maritime and energy sector customers.
Advanced ManufacturingEnergyLogistics & Supply ChainNew Materials
Len Gelosain
Co-investorsAdams Street PartnersJ.F. Lehman
Druva provides a cloud-native SaaS platform for data backup, protection, recovery, and AI-driven data insights across enterprise data and workloads.
Cloud ComputingCybersecuritySaaSSunnyvale, US
Milind Borate(Director)inJaspreet Singh(Founder & CEO)inMahesh Patel(Executive Officer)inEugenia Buzogly(Executive Officer)
BoardShailendra Jit Singh(Director)inJishnu Bhattacharjee(Director)in
Co-investorsArbor Ventures UKDell Technologies CapitalFounders Circle CapitalHercules Capital, Inc.IAN GroupOrios Venture Partners+11 more
A digital health resource platform providing medical professionals with educational information and clinical resources about transthyretin amyloid cardiomyopathy (ATTR-CM) and related cardiac and neurological conditions.
BiotechDigital HealthHealthtechSan Francisco, US
NEIL KUMAR(Executive Officer, Director)JONATHAN FOX(Executive Officer)UMA SINHA(Executive Officer)CHRISTINE SIU(Executive Officer)HOYOUNG HUH(Director)ERIC AGUIAR(Director)
Co-investorsAisling CapitalForesite CapitalRA CapitalViking Global Investors
FIGS designs and sells medical uniforms and apparel for healthcare professionals using proprietary technical fabric technology.
ConsumerDirect to ConsumerEnterprise SoftwareHealthtech
Heather Hasson(CEO and Co-founder)inTrina Spear(CEO and Co-founder)in
Co-investors500 GlobalBreyer CapitalG SquaredHighsage VenturesKarlin VenturesLead Edge Capital+3 more
GondolaBio is a clinical-stage biopharmaceutical company developing therapeutics for patients with genetic diseases, with a lead oral small-molecule program (PORT-77) targeting erythropoietic protoporphyria and X-linked protoporphyria.
BiotechHealthtech
Co-investorsAisling CapitalFrazier Life SciencesPatient Square Capital
Biotech company developing antibodies to treat autoimmune and inflammatory diseases.
Co-investorsAlpha Wave GlobalArkin CapitalArkin Digital HealthJeito CapitalMonograph Capital PartnersARCH Venture Partners+1 more
Vaccine development platform using computationally designed synthetic virus-like particles
BiotechSeattle, US
Charles Richardson(Senior Vice President, Technical Operations)Adam K. Simpson(President and Chief Executive Officer)Niranjan Kanesa-thasan(Chief Medical Officer)Douglas A. Holtzman(Chief Scientific Officer and Secretary)Cassia Cearley(Treasurer, Chief Business Officer)
BoardPeter Kolchinsky(Director)in
Co-investorsQiming Venture Partners USARA CapitalSanofi VenturesQiming Healthcare
Mclean, US
Matt Thompson(Executive Officer)inBlake Hall(Founder)inThomas Pouliot(Director)Alexander D. Perwich II(Director)
BoardNathan McKinley(Director)Kelly Perdew(Director)in
Co-investorsBoxGroupBuilders + BackersCapitalGFortify VenturesFTV CapitalJHH vc+11 more
Impossible Foods produces plant-based meat alternatives, including beef, pork, chicken, and sausage products designed to replicate the taste, nutrition, and cooking properties of conventional animal meat.
ConsumerFoodTechHealthtechRedwood City, US
Pat Brown(Founder)inDavid Lee(Executive Officer)inPeter McGuinnessin
BoardBart Swanson(Director)inSamir Kaul(Director)inTai Ronnen(Director)
Co-investors1435 CapitalAliya Capital PartnersAllied Venture PartnersAngelDAOBlue Horizon CorporationCianna Capital+31 more
Iterable provides customer communication and engagement software that enables brands to create targeted messaging experiences across email, SMS, push, and other channels.
AI & Machine LearningEnterprise SoftwareMarketing TechMedia & EntertainmentSaaSSan Francisco, US
Andrew Boni(Co-founder, CEO (2021-2025))inJustin ZhuinHaoran Zhu(Executive Officer, Director)
BoardSabri Murat Bicer(Director)
Co-investors3Spoke Capital500 Global645 VenturesAngelPadArtisanal VenturesBrighter Capital+12 more
Keboola provides a data platform that helps organizations turn data into reliable decisions.
AI & Machine LearningClimate TechCloud ComputingData & InfrastructureFintechSaaS
Petr Simecek(Founder)in
Co-investorsPresto VenturesReflex CapitalTCF CapitalViking Global Investors
.jpg)
BiotechSan Diego, US
Stephen W. Kaldor(Executive Officer, Director, Promoter)Eric Murphy(Executive Officer, Director)
BoardBret Zbar(Director)Carl Gordon(Director)Michael Rome(Director)in
Co-investorsForesite CapitalNextech InvestJanus Henderson InvestorsRA CapitalVenrock Healthcare Capital PartnersViking Global Investors
Lightmatter builds photonic interconnect and compute technologies for AI infrastructure, enabling faster data transfer between processors in large AI clusters.
AI & Machine LearningData & InfrastructureHardwareSemiconductorsMountain View, US
Darius Bunandar(Founder, Chief Scientist)inThomas Graham(Founder, Head of Machine Learning)inNicholas Harris(Founder)inColin Sturt(Executive Officer)inSimona Jankowski(Executive Officer)
BoardErik Nordlander(Director)
Co-investorsAliya Capital PartnersBeaconsfield CapitalEastward Capital PartnersKhosla VenturesMatrixNearingpoint Venture Partners Inc.+5 more
Longboard Pharmaceuticals is a clinical-stage biopharmaceutical company developing small-molecule medicines targeting G protein-coupled receptors for neurological diseases, with an initial focus on rare conditions.
BiotechHealthtechSan Diego, US
Kevin Lind(President & CEO)inRandall Kaye(EVP & Chief Medical Officer)inBrandi Roberts(Chief Financial Officer)inSteven Spector(General Counsel / Head of Business Development)inChad Orevillo(Head of Clinical Operations)inLaurie Stelzer(Director)
MagentaMed develops the Elevate percutaneous Left Ventricular Assist Device (pLVAD), a low-profile, high-flow arterial pump for temporary mechanical circulatory support.
HardwareHealthtechMedical DevicesKadima, IL
Yosi Tuval(MSc – Co-Founder & CTO)Ehud Schwammenthal(MD, PhD – Co-Founder & CMO)inDavid Israeli(MD, MBA – Chairman & CEO)in
Co-investorsALIVE Israel HealthTech FundFresenius Medical Care VenturesNew Enterprise Associates (NEA)OrbiMedRA CapitalPitango
Irish company developing an advanced neurostimulation device.
HealthtechPlymouth, US
Dan Sachs(Director)Peter Crosby(Executive Officer, Director)inJason Hannonin
BoardManus Rogan(Director)inAntoine Papiernik(Director)in
Co-investorsFountain Healthcare PartnersIreland Strategic Investment FundSeventure PartnersSofinnova PartnersAlly Bridge GroupGilde Healthcare+1 more
Metsera was a clinical-stage biotechnology company developing injectable and oral medicines for obesity and metabolic diseases, including next-generation GLP-1 and amylin-based therapies.
BiotechHealthtechMedical DevicesNew York, US
Clive A. Meanwell(Director)Christopher J. Visioli(Executive Officer)inBrian Hubbard(Executive Officer)inChristopher Whitten Bernard(Executive Officer, Director)Steven Marso(Executive Officer)
BoardKristina Burow(Director)in
Co-investorsAlpha Wave GlobalARCH Venture PartnersF-Prime CapitalGV (Google Ventures)RA CapitalSoftBank Vision Fund+5 more
Moderna develops mRNA-based medicines for infectious and serious diseases using its proprietary mRNA platform and design technology.
BiotechDeep TechMedical DevicesCambridge, US
Robert Langer(Director)Noubar Afeyan, Ph.D.(Co-founder and Chairman, Moderna; CEO, Flagship Pioneering)Lorence Kim(Executive Officer)inJames R. Kasinger(Executive Officer)inStephen Hoge(Executive Officer)in
BoardStephane Bancel(Chief Executive Officer)in
Co-investorsAglae VenturesBlackstone Life SciencesFlagship PioneeringFPVKhosla VenturesLingotto+5 more
MyForest Foods produces farm-grown mycelium as a new whole-food category, developing plant-based food products aimed at consumers seeking nutritious and environmentally friendly options.
AgTechBiotechClimate TechFoodTechGreen Island, US
Eben Bayer(Co-Founder & Board Chair)inPatricia Strickland(Executive Officer)Stephen Lomnes(Executive Officer)inDeb Battista(Chief Growth Officer)inDebra Antonelli(Chief People Officer)
BoardShally Shanker(Director)in
Co-investorsStray Dog CapitalUnovis Asset ManagementAiiM PartnersFootPrint CoalitionViking Global Investors
Mythic Therapeutics was a clinical-stage biotech developing next-generation antibody-drug conjugates for cancer using its proprietary FateControl technology.
BiotechWaltham, US
Brian Fiske(Executive Officer, Director)George Eliades(Executive Officer, Director)inSandra Poole(Executive Officer)inAlex Nichols(Executive Officer, Director, Promoter)
BoardBryan Roberts(Director)inPeter Hecht(Director)
Co-investorsForesite CapitalHemi Ventures, LlcLifeforce CapitalNat TurnerRefactor CapitalVenrock Associates
Neurona Therapeutics is a clinical-stage biotherapeutics company developing allogeneic neural cell therapies to treat chronic disorders of the nervous system.
BiotechDeep TechHealthtechSouth San Francisco, US
Cory Nicholas(Executive Officer, Director, Promoter)inJames Stutz(Chief Financial Officer and Chief Business Officer)inCatherine Priest(Chief Development Officer)inGautam Banik(Chief Technology Officer)inEduardo Dunayevich(Chief Medical Officer)inArnold Kriegstein(Director)
Co-investorsBerkeley FrontierIaso VenturesThe Column GroupYsios CapitalAlexandriaFidelity Investments+8 more
Pearl Health provides tools, intelligence, and support to primary care providers and healthcare organizations to deliver proactive care within value-based care models.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechNew York, US
Michael Kopko(Board Member, CEO)in
BoardJeffrey De Flavio(Executive Chairman)inVineeta Agarwala(Director)inScott Kupor(Director)inJeff DeFlavio(Director)inKevin Ryan(Director)in
Co-investorsAndreessen HorowitzAlleyCorpAlumni VenturesBasecamp FundFloating PointOffline Ventures+5 more
Pharvaris develops investigational oral therapies for people living with bradykinin-mediated angioedema.
BiotechHealthtech
Co-investorsBain Capital Life SciencesForesite CapitalKurma PartnersvenBio Partners
PMV Pharma develops precision oncology therapies that target and structurally correct mutated p53 proteins to restore their tumor-suppressing function.
BiotechHealthtechCranbury, US
David H. Mack, Ph.D.(Founder)inDavid Mack(Executive Officer, Director)Arnold Levine(Director)
BoardPeter Thompson(Director)inSteve Winick(Director)Arnold Oronsky(Director)
Co-investorsAvoro Capital AdvisorsNextech InvestOUP (Osage University Partners)RA CapitalWellington ManagementOrbiMed+1 more
Computational microbiome analysis platform for immunologic disorders
Co-investors3CC | Third Culture CapitalGood AI CapitalHarmonix FundIaso VenturesJoyance PartnersMerck Global Health Innovation Fund+4 more
RayzeBio develops radiopharmaceutical therapies for cancer treatment.
BiotechHealthtechMedical DevicesSan Diego, US
Ken Song(Executive Officer, Director)inBen Hickey(President)inAbhi Bhat, PhD(Senior Vice President, Research & Development)Deborah Charych(Executive Officer)Yi Larson(Director)
BoardAaron Royston(Director)in
Co-investorsLifeSci Venture PartnersSamsara BioCapitalScion Life SciencesSofinnova VenturesTCG CrossovervenBio Partners+4 more
SetPoint Medical develops an FDA-approved implantable neurostimulation device that stimulates the vagus nerve to reduce inflammation, offering a device-based treatment for adults with moderate-to-severe rheumatoid arthritis who have not responded to biologic or targeted synthetic drugs.
BiotechHealthtechMedical DevicesValencia, US
Murthy Simhambhatla(CEO)inDavid Chernoff(Chief Medical Officer (MD))Yaakov Levine(PhD)inRohan Seth(Executive Officer)in
BoardBlake Wu(Director)inJuan-Pablo Mas(Director)in
Co-investorsAlly Bridge GroupNew Enterprise Associates (NEA)Norwest Venture PartnersTopspin PartnersAsahi Kasei Corporate Venture CapitalCatalio Capital Management, LP+7 more
Sprout Pharmaceuticals is a pharmaceutical company focused on women's sexual health, known for developing Addyi (flibanserin), the first FDA-approved treatment for low libido in women.
BiotechFemTechHealthtechRaleigh, US
Robert S. Whitehead(Director, Executive Director)Cindy Eckert(Founder)Cynthia Whitehead(Chief Commercial Officer)Anne Tomalin(Vice President, Global Regulatory Affairs)Matthew Petzold(Chief Financial Officer and Treasurer)Douglas Eckert(Director, Secretary)
Co-investorsScientia Ventures
Star Therapeutics develops treatments aimed at addressing real-world patient needs.
BiotechSouth San Francisco, US
Adam Rosenthal(Founder & CEO)inNancy Stagliano(Director)inMichelle Carpenter(Executive Officer)Sandip Panicker(Executive Officer)Scott Robertson(Executive Officer)inGary Patou(Executive Officer)in
Co-investorsFrazier Life SciencesOrbiMedRA CapitalSanofi VenturesSofinnova VenturesAgent Capital+11 more
Clinical-stage biotech developing cell therapy products for transplant and autoimmune conditions
BiotechLouisville, US
Suzanne Ildstad(Executive Officer, Director)Scott Requadt(Executive Officer, Director)Geoff Mackay(Director)Francois Nader(Director)
BoardSandip Agarwala(Director)inMark McDade(Director)in
Co-investorsAisling CapitalKeyhorse CapitalLongitude CapitalQiming Venture Partners USABlackstone Life SciencesCitadel+3 more
Talkdesk is a cloud-based customer experience platform that enables organizations to optimize contact center operations, improve agent efficiency, and deliver customer service at scale.
AI & Machine LearningCloud ComputingDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US
Tiago Paiva(CEO)inCristina Fonsecain
BoardJosh Stein(Director)in
Co-investors3Spoke Capital500 GlobalAmity VenturesSaaStr FundSGH CapitalStorm Ventures+6 more
Triveni Bio develops genetics-informed antibody therapeutics aimed at treating complex immunology and inflammation (I&I) diseases.
BiotechDigital HealthHealthtech
Co-investorsAscenta CapitalAtlas VentureBorealis VenturesBorealis VenturesMagnetic VenturesOrbiMed+4 more
Vector Biomed develops lentiviral vectors for cell and gene therapy, focusing on affordable, scalable vector solutions with transparent pricing and no hidden royalties.
Advanced ManufacturingBiotechHealthtechMedical DevicesGaithersburg, US
Boro Dropulic(Executive Officer, Director)inJames Kenny(Director)Peter Lee(Director)
A biopharmaceutical company developing medicines and vaccines with a focus on clinical research and development for human health.
BiotechSan Diego, US
David Johnson(Executive Officer, Director)Cam Gallagher(Director)Scott L. Glenn(Director)in
Co-investorsChiesi VenturesDecheng CapitalPappas CapitalSofinnova VenturesVedanta CapitalArix Bioscience+4 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AbCellera BiologicsAbdera TherapeuticsAffinivaxAllonniaAltimmuneAmplifyBioAMVKGAmylyx PharmaceuticalsAntheiaAPi GroupArcaeaArtivaAthira PharmaAyana BioCallstackCanopyCovetrusDamora TherapeuticsDeciphera PharmaceuticalsEcovativeEnsomaEnstructureGenomaticaGT Medical TechnologiesHarvester Acquisition CorpHeadLight TechnologiesHumanevaIllumina AcceleratorInhibrxInternational Literary PropertiesJoyn BioLianBioLiberty Media Formula OneMachine SciencesMotif FoodWorksNewAmsterdamNova AnchoraNuvalentPatina HealthRevenovaRevive EnvironmentalRockefeller Capital ManagementRoivant SciencesSampledStandard BioToolsTIC SolutionsTrailhead MediaValsoftValstoneVeradermicsVerb BioticsViela BioVoyadoYesToZ-Alpha TherapeuticsZentalis Pharmaceuticals
Exits · 19
15 IPOs · 4 acquisitions · showing 174D Molecular TherapeuticsNASDAQ: FDMTAdaptive BiotechnologiesNASDAQ: ADPTaTYR PHARMANASDAQ: ATYREdgewise TherapeuticsNASDAQ: EWTXEditas MedicineNASDAQ: EDITGinkgo BioworksNYSE: DNAORIC PharmaceuticalsNASDAQ: ORICOruka Therapeutics IncNASDAQ: ORKAPepGenNASDAQ: PEPGPROCEPT BioRobotics CorpNASDAQ: PRCTRallybio, LLCNASDAQ: RLYBSionna TherapeuticsNASDAQ: SIONTrevi TherapeuticsNASDAQ: TRVIUberNYSE: UBERVerastemNASDAQ: VSTMHI-Bioacq. by BiogenMetseraacq. by Pfizer
Portfolio news
latest coverage across their companiesTrevi Therapeutics · simplywall.st · Aug 1, 2026
Credit Karma · creditkarma.com · Jul 13, 2026
Pearl Health · prnewswire.com · Jul 8, 2026
Triveni · finsmes.com · Jun 17, 2026
City Therapeutics · finsmes.com · Jun 9, 2026
AlphaSense · finance.yahoo.com · Jun 3, 2026
Frequently asked questions
- How many investments has Viking Global made?
- Viking Global has 130 tracked investments, 19 of which have exited.
- What stage does Viking Global invest at?
- Viking Global invests at the Growth, Late Stage stages.
- What sectors does Viking Global focus on?
- Viking Global focuses on Advanced Manufacturing, Healthtech, Sector Agnostic.
- Where is Viking Global located?
- Viking Global is headquartered in Stamford, US.
- Who does Viking Global co-invest with?
- Viking Global most often shares deals with RA Capital, Foresite Capital, Frazier Life Sciences, among 336 tracked co-investors.
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
.png)
General Catalyst is a venture capital firm operating as a partnership focused on company building and accelerating the growth of the businesses it backs.
Insight Partners is an investment firm focused on accelerating revenue and profit growth in software companies, providing capital and operational support through its Insight Onsite team.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.